Good on 217.3mil. , plus 10,000,000 Series A Preferred Shares from HAF Capital Advisors LLC. when and if converted, $SNST
represents a 50.01% ownership
217,320,536 shares of Sunset common stock
$SNST http;//www.aphexus.com Pursuant to the Agreement,
Sunset has acquired all of the issued and outstanding shares of the common stock of Aphex in exchange for 217,320,536 shares of Sunset common stock.
Sanitech Holdings Inc. through its purchase of 10,000,000 Series A Preferred Shares from HAF Capital Advisors LLC. when and if converted,
represents a 50.01% ownership of the voting control of Sunset Capital Asset Inc. and its survivor entity.
09-26-2020
$SNST [TRUE] I DO BELIEVE SOME CAUSE, I GOT TRAPPED BEFORE. OVERBOUGHT PPS AS OF 09-25-2020 IMHO. $SNST
[bad history so far]
i loss $XX,XXX on first one & $X,XXX SOLUTION 2ND new adventure [ SANITISE SULUTIONS ] 
RE;
SCAM-SCAM-SCAM!!!
THIS IS FOLLOWING THE EXACT SAME SCENARIO THAT SUNSET USED LAST TIME.
LOTS OF PRESS,
LOTS OF HYPE,
ONE FINANCIAL STATEMENT NEVER CHANGED OVER A FEW YEARS BUT ALWAYS PROMISED, PROMISES OF GOING ON THE EXCHANGE THAT NEVER HAPPENED,
AND LOTS OF WORDS INDICATING MAYBE THIS AND MAYBE THAT.
ALL BULLSHIT.
IT ISSUED RESTRICTED STOCK SO YOU COULDN'T EVEN TOUCH THE SHARES.
WENT DOWN TO $0.
ANNSWER IS;
T R U E [Sunset Capital Assets, Inc. ] ALL OF A SUDDEN THEY SHOW UP AGAIN WITH A NEW SCAM. http://www.aphexus.com Phone: 1-585-386-0990 Address: Aphex BioCleanse Systems Inc. TALK TO THE PRESIDENT AND LET HIM TELL YOU ABOUT HOW HE IS PROTECTING HIS FAMILY BY GETTING THEM TO BUY THE STOCK.
BEWARE!!! [CAUTION]
ANSWER T R U E
DONT BELIEVE ME. JUST READ THE PAST COMMENTS ON THIS SITE FROM A FEW YEARS AGO WHEN THEY WERE DOING THE SAME THING
WITH SOME FAKE STATUES WORTH MILLIONS. CRAZY! THEY ARE A FRAUDULENT COMPANY JUST TAKING YOUR MONEY. BEWARE!
ANSWER T R U E Aphex BioCleanse Systems Inc, OTC, SNST, continuing to expand production
at its new manufacturing location in Port Richey FL.
Press Release | 08/10/2020
Aphex BioCleanse Systems Inc, OTC, SNST, continuing to expand production
at its new manufacturing location in Port Richey FL.
PR Newswire
PITTSFORD, N.Y., Aug. 10, 2020
PITTSFORD, N.Y., Aug. 10, 2020 /PRNewswire/
-- Aphex BioCleanse Systems Inc. (OTC: SNST) announces today that the Company is continuing the buildout and expanding production of its revolutionary non-alcohol,
non-toxic hydrogen based germ killing formula Hy-IQ™ at its Port Richey Florida facility.
The buildout design has been completed and General Contracting work will commence in the near future.
[-chart]mma.prnewswire.com/media/1225877/PortRichyPhoto1.jpg[/chart]
David J Weaver, CEO, says,
"We have produced and shipped over two hundred 275 Gallon Totes since March of this year with our current manufacturing capacity.
Once complete, the new manufacturing facility will allow us to produce up to 90 totes per day including Ready To Use (RTU) solution
and also up to 10X Concentrate solutions for shipment in the United States and globally.
The current pandemic crisis has significantly increased demand for non-alcohol sanitizing."
About Aphex BioCleanse Systems, Inc.
Aphex BioCleanse Systems Inc has developed a proprietary broad-based germ-killing formula trademarked as Hy-IQ ™ Water.
The Non-Toxic, Non-Alcohol, Hydrogen Based Trade Secret formulation
has a unique method of action that uses hydrogen ions traveling at
the speed of light to breach the cell walls of exoskeleton germs.
Significant prior testing has proven the formula's ability to effectively kill a broad base of pathogens.
"Hy-IQ, may be the most significant discovery in disinfecting since
the discovery of chlorine in 1774," says Aphex CEO, David Weaver. www.aphexus.com
FDA Statement
The statements in this document have not been evaluated or approved by the FDA.
The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties
and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition.
The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
ShareholderInfo@aphexus.com
http://www.aphexus.com Phone: 1-585-386-0990
Address:
Aphex BioCleanse Systems Inc.
15 Fishers Rd, #111
Pittsford, NY 14534
[-chart]mma.prnewswire.com/media/1225878/PortRicheyphoto2.jpg[/chart]
View original content to download multimedia:
http://www.prnewswire.com/news-releases/aphex-biocleanse-systems-inc-otc-snst-continuing-to-expand-production-at-its-new-manufacturing-location-in-port-richey-fl-301109020.html SOURCE Aphex BioCleanse Systems Inc.
Aphex BioCleanse Systems Inc., http;//www.aphexus.com https://www.aphexus.com/management/ https://www.aphexus.com/sanaphex/ 
https://www.aphexus.com/dermraphex/ 
https://www.aphexus.com/medaphex/ 
https://www.aphexus.com/vegaphex/ 
https://www.aphexus.com/wp-content/uploads/2020/06/green-bottle-green-top.jpg Aphex™ Independent Lab Test Data
Killing germs is a serious business. At Aphex™ BioCleanse Systems, we back our products with independent lab testing.
Our products are tested continually in order to assure the high-quality results our customers expect and deserve.
At Aphex™ we develop complete protective systems for many industries, and each of our products is put through
a rigorous series of tests to maintain our high standards.
Important Note Regarding Product Name Change
Our hand sanitizer line has recently undergone a re-branding based on our market research.
Because of the hydrating effect, our product has on skin tissue (human as well as animal) we renamed our hand sanitizer from “DermAphex” to “HydrAphex™”.
This new name embodies the natural essence of our product.
The following test results were derived prior to the name change, and as a result, the test data refers to DermAphex instead of our new name.
Our formulations have not changed since these tests were conducted, and therefore the data is applicable to our
HydrAphex™ product line exactly as it was for the DermAphex product mentioned within the following reports.
https://www.aphexus.com/contact/ https://www.aphexus.com/test-data/ This is the biggest Bioscience breakthrough in our lives. It will change the world. Most every surface,
every hand every building and everything else discussed here will likely be sanitized with HY-IQ.
My question to each and everybody who reads this....DO YOU KNOW HOW THE PRODUCT WORKS ?
It's not chemicals...it's not some fancy lights that don't work.
This is a pure physics reaction 1000's x more effective than any sanitizer.
HY-IQ kills all viruses, all spores, all exoskeletal bugs instantly. No chance for mutation.
Do you know how ? If you do, you'll realize this is a multi, multi billion $ business out of the gates.
I will put out some explanation this week how it specifically works.
Can you imagine most every private label in the world coming to APHEX to buy HY-IQ to put in their packaging ?
$SNST Sunset Capital Assets, Inc., OTC, SNST, Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc. Press Release | 08/03/2020 JACKSONVILLE, FL / ACCESSWIRE / August 3, 2020 / Sunset Capital Assets Inc. (OTC PINK:SNST) announces today
that the Company has signed and executed a definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc.
http;//www.aphexus.com Pursuant to the Agreement,
Sunset has acquired all of the issued and outstanding shares of the common stock of Aphex in exchange for 217,320,536 shares of Sunset common stock. Sanitech Holdings Inc. through its purchase of 10,000,000 Series A Preferred Shares from HAF Capital Advisors LLC. when and if converted,
represents a 50.01% ownership of the voting control of Sunset Capital Asset Inc. and its survivor entity. Commensurate with the closing of the transaction, the Company intends to revise its capital structure and management,
change its name to Aphex BioCleanse Systems Inc., and apply for a change in trading symbol.
Sunset Executives and Board of Director members,
John Watson, Sr., John Watson, Jr., Alan Speck and Anthony Betros have resigned as officers and directors of Sunset.
David Weaver has been appointed CEO and Director. Scott Buckley has been appointed to an officer position.
David Olund has been appointed to Sr. VP for Finance and Business Development and a Director.
Anthony Fedor was appointed as a Director. From this point on, all the Company's resources and efforts will be
focused on the continuation of Aphex's current and future development and operations. About Aphex BioCleanse Systems, Inc. Aphex BioCleanse Systems Inc has developed a proprietary broad-based germ-killing formula trademarked as Hy-IQ™ Water.
"The formula is potentially the most significant discovery in sanitizing and disinfecting since the discovery of Chlorine in 1774",
says Aphex CEO David Weaver.
Mr. Weaver further states that, "It is exciting to be participating on the front-line effort in the war on germs, especially in these trying times.
We look forward to building shareholder value through global sales and marketing into derivative platforms.
" Aphex is headquartered in Pittsford, NY. The company has achieved numerous positive kill tests on a wide range of pathogens and
will continue its pursuit of various required regulatory approvals.
Additionally, the company is expanding its production capacity in Port Richey, FL,
where it will produce hand and surface sanitizers blended to meet current regulatory requirements in an additional facility. FDA Statement The statements in this document have not been evaluated or approved by the FDA.
The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease. Safe Harbor Statement This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934.
These forward-looking statements are based on the current plans and expectations of management and are subject to
a number of uncertainties and risks that could significantly affect the company's current plans and expectations,
as well as future results of operations and financial condition.
The company undertakes no obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. RECTIFIED
https://www.prnewswire.com/news-releases/aphex-biocleanse-systems-inc-otc-snst-confirms-prior-judicial-liens-owed-by-predecessor-sunset-capital-assets-inc-as-satisfied-301105938.html PITTSFORD, N.Y., Aug. 4, 2020 /PRNewswire/ -- Aphex BioCleanse Systems Inc. (OTC-SNST) announces today
that the Company has received the filed and Completed Satisfactions of two Judicial Liens totaling $7,837,875
plus accruing statutory interest that remained on the Sunset Capital Assets Inc Balance Sheet. Effective July 31, 2020
and as previously reported on August 2, 2020, Sunset Capital Assets has acquired Aphex BioCleanse Systems and will operate as Aphex on a forward going basis. The final execution and performance of the definitive Share Exchange Agreement, dated July 31, 2020,
between Aphex BioCleanse Systems Inc and Sunset Capital Assets Inc.
satisfied the prerequisite requirements of the Judicial Lien Holder per a prior executed Settlement Agreement.
The Judicial Lien Satisfactions will be reflected on future Company Financial Reports to be made available
when due and reported on the OTC Pink Sheets market platform.
The Judicial Lien Satisfactions were filed with the St. Charles County, Missouri Clerk of the Court. $SNST
https://www.otcmarkets.com/stock/SNST/disclosure https://www.otcmarkets.com/stock/SNST/news https://www.otcmarkets.com/stock/SNST/security https://www.otcmarkets.com/stock/SNST/profile https://www.otcmarkets.com/stock/SNST/quote https://www.otcmarkets.com/stock/SNST/overview *DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.
News 
Market Data 
Discover 
